JSW Energy to raise ₹13,000 cr via securities, preferential issue to promoters

JSW Energy plans to raise ₹10,000 crore through qualified institutional placement and another ₹3,000 crore from the promoters ...
BMJ

Treating iron deficiency in patients with heart failure: what, why, when, how, where and who

For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an ...
IEEE

Reconfigurable Magnetic Microswarm for Accelerating tPA-Mediated Thrombolysis Under Ultrasound Imaging

Abstract: In this article, we propose a strategy to accelerate tissue plasminogen activator (tPA)-mediated thrombolysis using a microswarm under ultrasound imaging. The microswarm is formed in blood ...
Frontiers

Subacute edema progression after acute ischemic stroke: impact of intravenous alteplase administration and reperfusion degree

Introduction: Alteplase is known to increase the risk of blood-brain barrier integrity disruption, potentiating hemorrhage and edema. Evolving edema reduces chances of good functional outcomes. There ...
Contract Pharma

Genentech’s TNKase Approved by FDA for Treatment of Strokes

TNKase is the first stroke medicine approved by the FDA in nearly 30 years. The U.S. Food and Drug Administration (FDA) has approved Genentech’s TNKase (tenecteplase), a thrombolytic or ...
MedPage Today

Ultraprocessed vs Minimally Processed Food; Alteplase After Stroke

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...